Enoby Injection
Product Images NDC 0143-9165

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Enoby (NDC 0143-9165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoby Before Use (Enoby Denosumab Qbde Injection 1)

FDA Label Image

Enoby After Use (Enoby Denosumab Qbde Injection 2)

This description appears to mention used barrel, used needle, safety spring, grey needle, and cap off. This might refer to various components of a device or equipment that have been previously used or are being removed or replaced.*

FDA Label Image

Enoby Figure A (Enoby Denosumab Qbde Injection 3)

FDA Label Image

Enoby (Figure B)

This text mentions body parts that can be targeted for exercises or measurements, such as the upper arm, abdomen, and upper thigh. These areas are common areas of focus for fitness and health-related activities.*

FDA Label Image

Enoby Figure D (Enoby Denosumab Qbde Injection 5)

FDA Label Image

Enoby Figure E (Enoby Denosumab Qbde Injection 6)

FDA Label Image

Figure-1 (Enoby Denosumab Qbde Injection 7)

This is a comparison of hip fracture incidence between a placebo group (involving 3906 patients) and a denosumab group (involving 3902 patients), with the incidence rate stated as 10%. This data can be useful for evaluating the efficacy of denosumab in preventing hip fractures.*

FDA Label Image

Enoby_label (Enoby Denosumab Qbde Injection 8)

This text is a pharmaceutical label for a single-dose prefilled syringe of denosumab-ghde injection intended for subcutaneous use. The syringe must be discarded if any portion is unused. The product is manufactured by Hikima Pharmaceuticals USA Inc. and displays a NDC code of 0143-9165-01. The label also mentions a specific overlap distance of 2mm. The numbering area size is indicated as 14 x 10 mm. The document includes information about the company's US License No. 2356.*

FDA Label Image

Enoby_carton (Enoby Denosumab Qbde Injection 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.